Nontypeable Haemophilus influenzae: the role of N-acetyl-5-neuraminic acid in biology by Michael A Apicella
REVIEW ARTICLE
published: 13 March 2012
doi: 10.3389/fcimb.2012.00019
Nontypeable Haemophilus influenzae: the role of
N-acetyl-5-neuraminic acid in biology
Michael A. Apicella*
Departments of Microbiology and Internal Medicine, The Carver College of Medicine, The University of Iowa, Iowa City, IA, USA
Edited by:
W. Edward Swords, Wake Forest
University Health Sciences, USA
Reviewed by:
Robert J. C. McLean, TX State
University, USA
X. Frank Yang, Indiana University
School of Medicine, USA
*Correspondence:
Michael A. Apicella, Departments of
Microbiology and Internal Medicine,
The Carver College of Medicine, The
University of Iowa, 51 Newton
Road, Iowa City, IA 52242, USA.
e-mail: michael-apicella@uiowa.edu
Nontypeable Haemophilus influenzae (NTHi) is an exclusive human pathogen, which has
evolved a number of unique mechanisms to survive within the human environment. An
important part of this is the ability of the organism to take up and incorporate sialic acid into
its surface structures. This protects the organism against host adaptive and innate immune
factor as well as serving as a mechanism for sustaining itself within biofilms. Recent
evidence suggests that this also may be the source of the evolution of human antibodies
to non-human sialic acid structures, which can lead to inflammation in the host. In very
rare instances, evolution of antibodies to sialylated lipooligosaccharide (LOS) mimics of
human antigens can result in autoimmune disease.
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INTRODUCTION
Nontypeable (non-encapsulated) Haemophilus influenzae
(NTHi), a Gram-negative cocco-baccillus, is normally a human
nasopharyngeal commensal organism, which can become an
important human pathogen in both adults and children. In
years past, some investigators suggested that NTHi were variant
forms of encapsulated H. influenzae that had lost their capsule
during passage in vitro. With the identification of the capsular
biosynthesis genes and the advent of whole genome analysis,
it has been established that strains of NTHi lack the genetic
machinery involved in capsule biosynthesis. In addition, nonty-
peable H. influenzae affect different patient populations, cause
different infections, present different surface antigens to the host,
and are genetically different from the encapsulated strains.
In view of the fact that NTHi strains lack a capsular anti-
gen, investigators have searched for virulence factors associated
with this organism, which would confer protection against host
defense mechanisms, particularly those associated with comple-
ment mediated bactericidal activity. Among other Gram-negative
species, the lipopolysaccharide (LPS) is frequently a factor in con-
ferring resistance to complement mediated lysis. These organisms
generally have an LPS with repetitive O-antigen structures that
act as a shield, which deters formation of the complement attack
complex on the surface of the bacterium. NTHi also lacks the
genes associated with O-antigen formation and forms a surface
glycolipid structure, which has a lipid A–ketooxyoctanoate-
heptose core region capped by no more than nine to ten sug-
ars. This structure is embedded in the outer membrane of the
organism. Given the short carbohydrate component, this glycol-
ipid has been termed a “lipooligosaccharide (LOS)” to distin-
guish it from the O-antigen containing LPS structures found on
Gram-negative bacteria present in the gastrointestinal tract or in
the environment. In general, Gram-negative bacteria (Neisseria,
Haemophilus, and Moraxella) found on the non-gastrointestinal
mucosal surfaces of the airway and genital tract have LOS as their
principle glycolipids rather than LPS. A number of these species
are exclusive human colonizers and have evolved such that their
LOS structures mimic human glycosphingolipid antigens includ-
ing paragloboside, pK antigen and “i.” An important component
of this mimicry is the addition of N-acetyl-5-neuraminic acid
(Neu5Ac) to the terminus of the LOS structures. This enhances
the immune evasion provided by the antigenic mimicry and adds
a strong negative charge and hydrophilicity to the surface of the
organism, which also acts to reduce the potential for hydrophobic
interactions with host innate immune factors that would be detri-
mental to the organisms. Mandrell and co-workers first showed
that the majority of NTHi strains expressed LOS structures which
were sialylated and formed structures which mimicked human
glycosphingolipid antigens (Mandrell et al., 1992). The addition
of Neu5Ac to the LOS of NTHi increases the resistance of the
organism to killing by normal human serum. In chinchilla mod-
els of otitis media, the ability of NTHi to incorporate Neu5Ac
onto the LOS is crucial for development of the infectious process.
This would indicate that the ability of the organism to cap its LOS
structures with Neu5Ac is critical for the pathogenic potential of
the organism.
The genome of NTHi is relatively small (∼2.1–2.2Mb) and
it has adapted well to the very narrow nasopharyngeal environ-
mental niche in which it resides. This has resulted in the loss of
synthetic capabilities found in other Gram-negative organisms
with larger genomes. As an excellent example of environmental
adaptability, NTHi has lost the ability to synthesize Neu5Ac. This
might be surprising considering the importance of Neu5Ac for
its survival as a pathogen in the human environment. However,
NTHi lives in a sea of sialic acid (Neu5Ac) associated with the
mucins (15% of the carbohydrate structure is Neu5Ac) found on
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the airway surfaces. The organism has adapted a number of mech-
anisms to acquire, control, and incorporate this important sugar
into its membrane structures.
SIALIC ACID
Sialic acids (NeuAc) are a diverse family of nine carbon acidic
sugars, of which there are around 40 derivatives known to date
(Schauer et al., 1995). The most common sialic acid is N-5-
acetylneuraminic acid or Neu5Ac (Figure 1). This sugar is formed
by the condensation of N-acetylmannosamine-6-phosphate and
pyruvate (Figure 2). The most distinguishing features of the
molecule are the carboxyl group at C1 and the amino group at C5.
The carboxyl group at C1 gives themolecule a net negative charge,
and is responsible for its acidic nature. The molecule’s negative
charge and relatively large size are two key features in how it plays
a role in biology. NeuAc is usually the terminal sugar on carbohy-
drate structures (oligo- and polysaccharides), glycoproteins and
glycolipids of mammals, birds, fungi, bacteria metazoans, and
archaea.
NeuAc and its derivatives are found on cell membranes and
body fluids in all mammals and many higher order animals, as
well as pathogenic microorganisms. Typically only a few deriva-
tives of Neu5Ac are seen in each individual species. In addition
to this, the derivatives of NeuAc can be tissue or developmen-
tally specific. The molecule is typically modified at positions C1,
C4, C5, C7, C8, or C9. The most common NeuAc of mam-
malian cells are the N-acetylneuraminic acids (Neu5Ac) and
N-glycolylneuraminic acid (Neu5Gc) (Varki, 2001). The addi-
tion of a hydroxyl group to the amino moiety at position C5
forms Neu5Gc. Neu5Gc is fairly common in animal species other
than humans, but is found in humans only in association with
certain forms of cancer (Narayanan, 1994; Sillanaukee et al.,
1999). Normal humans are the exception, because of a muta-
tion in CMP-sialic acid hydrolase. This enzyme is responsible
for the addition of a single oxygen atom to Neu5Ac convert-
ing it to Neu5Gc (Brinkman-Van der Linden et al., 2000). In
humans, this enzyme has no hydroxylase activity because of a
large deletion caused by a deletion/frame shift mutation in the
human gene. In contrast, the great apes including the chim-
panzee, bonobo, gorilla, and orangutan, our closest animal rel-
atives, have a functional CMP-Neu5Ac hydrolase, and can express
Neu5Gc in large amounts. In some tissues, this is the predominate
NeuAc.
Other common forms of modification are O-methylation and
O-acetylation. These modifications can have a profound impact
on the properties of sialic acid. For example, acetylation at C9 can
make the sialic acid resistant to cleavage by sialidases, which cat-
alyze the removal of sialic acid from glycoproteins and glycolipids.
The metabolism and nucleotide derivatization of Neu5Ac is
well described (Figure 2). Entry of metabolites into the pathway
can occur at multiple points. Fructose and D-glucosamine can
be an entry point for the pathway. Neu5Ac and CMP-Neu5Ac
can enter the pathway in bacteria from the external environment
through dedicated cell membrane transporters (Martinez et al.,
1995).
SYNTHESIS AND INCORPORATION OF SIALIC ACID BY
MICROBES
Many pathogenic bacteria have evolved mechanisms to evade
human defense mechanisms based on the surface exposure of
Neu5Ac. A common theme in this mimicry is the incorporation
of Neu5Ac as a component of either the capsular polysaccharide
or the LOS or both. Based on an understanding of the biosyn-
thesis of sialic acid and the evolving elucidation of the genomes
of multiple microbes, Vimr and Lichtensteiger have described
at least four mechanisms of microbial surface sialylation (Vimr
and Lichtensteiger, 2002). These include de novo synthesis, donor
scavenging, trans-sialylation, and precursor scavenging. Neisseria
meningitidis serogroups B, C, Y, and W-135 can synthesize sialic
acid for incorporation into capsular polysaccharides and LOS.
Neisseria gonorrhoeae cannot synthesize or convert Neu5Ac to
the nucleotide sugar form and must scavenge the donor, CMP-
Neu5Ac, to sialylate its LOS structure. Trypanosoma cruzi does
not synthesize or catabolize free sialic acid. It expresses a develop-
mentally regulated sialidase, which it uses for surface sialylation
by a trans-sialidase mechanism. The sialyltransferase activity of
the sialidase is greater than its hydrolytic activity as long as the
appropriate galactosyl acceptor is available.
THE Neu5Ac OPERONS IN NTHi
H. influenzae scavenges the precursor, Neu5Ac, to sialylate its
LOS and biofilm. It must rely on scavenging of Neu5Ac from
FIGURE 1 | A diagrammatic representation of the catabolic (),
uptake genes (), and regulatory gene () of the two Sia operons
in the H. influenzae genome are diagrammed in Figure 1.
The intergenic region between the catabolic and uptake operons
contains the binding sites for SiaR (solid Line) and Crp (dotted
rectangle).
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FIGURE 2 | A composite model of Neu5Ac uptake, incorporation into
LOS and catabolism into the Krebs cycle is shown. The different steps in
the process is described in text.
the environment because it cannot synthesize Neu5Ac. In addi-
tion, it has the means to use Neu5Ac as a source of carbon
and nitrogen through a complex Neu5Ac catabolic system. The
genes involved in the transport and metabolism of Neu5Ac are
arranged in two adjacent tandem operons, which are transcribed
in opposite directions (Figure 1). The operon involved in Neu5Ac
transport contains three genes encoding for a Neu5Ac binding
protein (siaP), a transporter (siaT), and a protein which appears
to be a homolog of Escherichia coli yjhT that is involved in the
conversion of the β-anomer of Neu5Ac to the α-anomer (Severi
et al., 2008). The binding protein (SiaP) and transporter (siaT) are
homologous to a system of tripartite ATP-independent periplas-
mic transporters (TRAP) found in other bacterial species. These
transporters differ from the better-characterized ABC-protein
transporter family (Colli, 1993) in that they do not possess an
ATP-binding cassette protein and are not driven by ATP hydrol-
ysis but rather by an electrochemical ion gradient (Haft et al.,
1996) (Figure 3). When the amino acid sequences of the NTHi
binding protein and other members of this family of solute-
binding proteins were aligned, the comparison allowed for the
identification of three major groups based on sequence sim-
ilarity and putative substrate: Neu5Ac, C4-dicarboxylates, and
pentose sugars. Surface plasmon resonance studies in which
the Neu5Ac was replaced with glucose, galactose, glucosamine,
N-acetylglucoamine, or N-acetylmannosamine showed that SiaP
did not bind any of these sugars. From the isothermal calorime-
try data it was determined that the stoichiometry of binding
of NeuAc to SiaP was 1:1. Severi et al. reported that the SiaP
from H. influenzae RM118 had a stoichiometry of 1:1 and a
Kd of 0.12 μM (Severi et al., 2005). The Kd values suggest that
the SiaP/NeuAc binding interaction is a high affinity interaction.
The failure of SiaP to bind KDO, an eight-carbon keto sugar, is
indicative of the high specificity of this binding protein. The crys-
tallographic structure and binding characteristics of this protein
have been described (Severi et al., 2005; Johnston et al., 2008).
Evidence that SiaT was the Neu5Ac transporter was shown
by the fact that NTHi siaT and siaTnanA mutants were both
incapable of sialic acid uptake (Johnston et al., 2008). This indi-
cated that the siaT gene product is required prior to activation of
Neu5Ac by the CMP-sialic acid synthetase, thus implicating SiaT
as the transporter in NTHi. Based on hydrophobicity plots, the
Neu5Ac transporter appears to have 16 transmembrane domains.
It is a fused version of the DctP/DctM proteins found in other
TRAP transporter systems (Figure 2).
Sialic acids on glycoconjugates are sequestered as the α-
anomer, while sialic acid in solution has been shown to slowly
mutorotate from the α-anomer to the β-anomer. The E. coli yjhT
homolog has been shown to convert this β-anomer of sialic acid
back to the α-anomer (Severi et al., 2008). It is believed that
the function of the NTHI gene in this uptake operon fulfills this
function for NTHi.
The metabolic operon consists of five genes involved in
metabolizing Neu5Ac and a gene involved in the regulation of
the uptake and metabolic process (Figure 1). The five metabolic
genes are nanE, nanK, nanA, nagB, and nagA, which encode
N-acetyl-mannosamine-6-phosphate-2-epimerase, N-acetyl-
mannosamine kinase, N-acetyl-neuraminate lyase, glucosamine-
6-phosphate deaminase, and N-acetyl-glucosamine-6-phosphate
deacetylase.
NTHi CMP-Neu5Ac SYNTHASE
Prior to its transfer to glycolipids and glycoproteins, sialic acid has
to be activated by the addition of a cytidine-5′-monophosphate
(CMP) group (Figure 2). This activation of sialic acid is abso-
lutely essential for sialylation to occur. A very unique feature
of this activation is the presence of only one phosphate in the
nucleotide/sugar linkage (Tullius et al., 1996), as opposed to two
present in most other sugar nucleotides (Kean, 1991). A gene
responsible for this activity has been identified in a number of
bacterial organisms, including E. coli, Streptococcus agalactiae,
N. meningitidis, H. ducreyi, andH. influenzae (Zapata et al., 1989;
Ganguli et al., 1994; Haft et al., 1996; Tullius et al., 1996; Hood
et al., 1999). The gene, called neuA, in E. coli, and N. meningi-
tidis is part of their capsular loci. The neuA gene in H. ducreyi
shares homology to other known CMP-NeuAc synthetases, and
is transcriptionally coupled to its sialyltransferase gene (Tullius
et al., 1996; Bozue et al., 1999). This same gene in H. influenzae
(designated siaB) is not in close proximity with any other known
LOS, capsule, or sialylation genes (Hood et al., 1999). In all cases,
a deletion in the CMP-NeuAc synthetase results in no detectable
sialic acid in the LOS, LPS, or capsules of the organisms.
NTHi SIALYLTRANSFERASES
The sialyltransferases from bacteria catalyze the same basic reac-
tion as the mammalian sialyltransferases. There are key differ-
ences in how they are isolated, their structures, and the speci-
ficity for acceptor structures, however. Bacteria contain sialy-
lated structures in either their LOS/LPS or in their capsule. A
great deal of work has been done on Neisserial sialyltransferases
from both N. gonorrhoeae and N. meningitidis. To date, there
have not been any bacterial sialyltransferases identified that have
homology to mammalian sialyltransferases. Most notably, there
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FIGURE 3 | A diagram showing the transmembrane loops of SiaT based on a hydrophobicity plot. The regions corresponding to DctQ and DctM are
shown. Model based on prediction program at http://proteinformatics.charite.de/rhythm/index.php?site=helix.
is no homology to the “classic” sialylmotifs of these mammalian
enzymes. For this reason, identification by PCR or Southern
hybridization using mammalian sequences has not been possible.
Sialyltransferases from both N. meningitidis and N. gonor-
rhoeae LOS were first cloned and characterized by Gilbert et al.
(1996). They were cloned by screening a DNA library made from
a strain of N. meningitidis. Using a sensitive enzyme assay based
on the transfer of sialic acid to synthetic fluorescent acceptors,
this group was able to identify a sialyltransferase capable of trans-
ferring NeuAc with an α2,3-linkage to a N-acetyllactosamine
acceptor. Strains of N. meningitidis capable of producing a sialic
acid capsule contain a α2,8-polysialyltransferase in addition to the
α2,3-sialyltransferase (Edwards et al., 1994).
Once the gene from N. meningitidis was cloned, probes were
made to amplify a similar enzyme from N. gonorrhoeae. There
was a high degree of homology between the two sialyltransferases,
with only 16–17 amino acid differences sporadically located along
the length of the 371 amino acid proteins (Gilbert et al., 1996).
In addition to not containing any homology to the sialylmo-
tifs of the mammalian sialyltransferases, these bacterial enzymes
had more ambiguity in the acceptor structures they could recog-
nize. Although there was a preference for theN-acetyllactosamine
structure, sialic acid could also be transferred to lactose or galac-
tose. In a more detailed study of the enzymatic properties of
this enzyme, it was shown that NeuAc could be transferred to
α-terminal or β-terminal galactose residues and β1,4-linked or
β1,3-linked galactose (Gilbert et al., 1996). Ambiguity was also
observed in the type of sialic acid able to be transferred, as N-
propionylneuraminic acid and NeuGc could also be used with
reduced efficiency.
A sialyltransferase has also been identified using a genetic
approach inH. ducreyi. The LOS structure sialylated inH. ducreyi
contains a terminal lactosamine structure (Melaugh et al., 1992,
1994). A gene was identified in this organism, designated lst,
which was located downstream of neuA (a CMP-NeuAc syn-
thetase) (Bozue et al., 1999). Mutational analysis of the two genes
indicated that they are transcriptionally linked. The lst gene is
thought to represent a novel class of bacterial sialyltransferases,
because it does not contain strong homology to any known bac-
terial or mammalian sialyltransferases and contains only weak
homology to the E. coli capsular polysialyltransferase (Vimr et al.,
1992; Bozue et al., 1999).
Campylobacter jejuni is able to synthesize a number of sia-
lylated LPS structures, some of which mimic human ganglio-
sides (Moran et al., 1991; Aspinall et al., 1993; Prendergast
et al., 1998; Gilbert et al., 2000; Guerry et al., 2000). C.
jejuni strain OH4384 produces an LPS similar to the gan-
glioside GD1a (NeuAcα2–8NeuAcα2–3Galβ1–3GalNAcβ1–4Gal-
(NeuAcα2–3)β1,3Hep). Using the same strategy used to clone the
Neisseria sialyltransferases, two genes were identified that con-
tained sialyltransferase activity, designated cstI and cstII (Gilbert
et al., 2000). There was a great deal of homology between the two
genes, and it was hypothesized that cstI occurred through a dupli-
cation event and subsequent genetic drift. CstI transfers NeuAc
α2,3-linked to lactose, while CstII was shown to be bi-functional,
capable of transferring sialic acid α2,3-linked to either lactose or
α2,8-linked to another NeuAc.
Another novel class of bacterial sialyltransferases was identi-
fied in the marine bacterium Photobacterium damsela (Yamamoto
et al., 1998). The protein was purified using a detergent
extract, which was also required for activity, indicating it was
a membrane-associated protein. Further analysis of the cloned
gene (bst) revealed a predicted α-helical structure in the C-
terminus that could function in membrane insertion (Yamamoto
et al., 1998). Deletion of this C-terminal sequence resulted in
the detection of the soluble enzyme in the supernatant. Enzyme
assay analysis showed that both lactose and N-acetyllactosamine
were the preferred acceptor structures, however NeuAc could
be transferred to either a galactose or a N-acetylgalactosamine
(Yamamoto et al., 1996). The most surprising function of this
enzyme was its linkage specificity, transferring NeuAc α2,6-linked
to the terminal sugar. This was the first identified bacterial sia-
lyltransferase to preferentially add sialic acid with this linkage.
Wakarchuk et al. identified an α2–6-linked sialic acid attached
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to a Pk antigen structure (Galα1–4Galβ1–4Glc) on the LOS of
N. meningitidis (Wakarchuk et al., 1998). It is not known if there
is a second sialyltransferase involved in this linkage, or if the α2,3-
sialyltransferase already identified in this organism can account
for this activity.
The sequenced genome of H. influenzae strain Rd has greatly
increased the ability to identify genes involved in LOS biosynthe-
sis, including sialyltransferases (Fleischmann et al., 1995). There
are at least four genes in the NTHi databases with homology to
known sialyltransferases, these are lic3A (Hood et al., 2001), lsgB
(Jones et al., 2002), siaA (Jones et al., 2002), and lic3B (Fox et al.,
2006). The first gene encoding an NTHi sialyltransferase iden-
tified was lic3A. Lic3A has approximately 40% identity (at the
protein level) to cstII from C. jejuni (Hood et al., 2001). Lic3A has
been shown to sialylate a galactose (sialyl-α-(2−3)-lactosyl exten-
sion) as part of a lactosyl group coming from the distal heptose.
As shown by Hood and co-workers, the activity is modulate by
competition for the acceptor by LgtC (Hood et al., 2001). The sec-
ond and third sialyltransferase found in H. influenzae were LsgB
and SiaA (Jones et al., 2002). LsgB has 27% identity and 46%
similarity to the N. meningitidis α2–3 sialyltransferases (Phillips
et al., 2000; Jones et al., 2002; Fox et al., 2006). Sia has 44% iden-
tity and 60% similarity with Lst from H. ducreyi over the entire
length of the proteins (Bozue et al., 1999; Jones et al., 2002).
Lst has been shown to be an H. ducreyi a2–3 sialyltransferase
(Bozue et al., 1999; Jones et al., 2002). Findings indicate that this
protein adds sialic acid to a terminal N-acetyllactosamine struc-
ture on the LOS (Jones et al., 2002). Fox and co-workers have
identified the most recent sialyltransferase in NTHi, Lic3B. This
enzyme is a very close homology of Lic3A and is present in over
50% of NTHi strains tested (Fox et al., 2006). Like lic3A, this
enzyme has been shown to be phase variable based on the tan-
dem repeats tetranucleotide CAAT repeats just within the 5′ end
of the open reading frame. Lic3B also appears to be bifunctional
similar the Cst1 found in C. jejuni. Lic3B has both α2–3 and
α2–8 sialyltransferase activities as well as trans-sialidase activity
(Fox et al., 2006).
A trans-sialidase is a bi-functional enzyme first found in the
genus Trypanosoma. The enzyme catalyzes two reactions. The first
is a trans-sialidase reaction, where sialic acid is cleaved from gly-
coconjugates free in solution or attached to a host membrane.
The sialic acid can then either be hydrolyzed to form free sialic
acid, or transferred to a mucin like glycoprotein found on the
Trypanosoma cell surface (Schenkman et al., 1994). The enzyme
has been identified in two pathogenic forms of Trypanosomes;
T. brucei, the causative agent of African sleeping sickness, and
T. cruzi, the causative agent of Chagas disease. The biological
properties of trans-sialidases have been studied by a number
of investigators (Colli, 1993; Cross and Takle, 1993; Schenkman
et al., 1994). Trans-sialidases have a very high specificity for α2,3-
linked sialic acid attached to a penultimate galactose residue on
host glycoconjugates. The enzyme is not able to transfer either
free Neu5Ac or CMP-Neu5Ac. The best acceptor structure is lac-
tose, but maltose (Glcα1–4Glc) or cellobiose (Glcβ1–4Glc) can be
used with decreased efficiency. The pH optimum for TS is around
7.0, which is different from the other sialidase enzymes, which
have a pH optimum between 5.0 and 5.5.
While evidence for similar trans-sialidase activity in NTHi has
not been conclusively shown, Lic3B could potentially have the
capability of removing Neu5Ac from mucin if it can be secreted.
Whether it would function extracellularly similar to the trans-
sialidase in Trypanosomes has not been shown and there is no
evidence for secretion or an export mechanism for the enzyme.
ROLE OF Neu5Ac IN NTHi PATHOGENESIS
Neu5Ac plays an important role in pathogenesis of NTHi infec-
tion in serum sensitivity, biofilm formation and the evolution of
human antibodies to glycosyl structures containing N-glycol-5-
neuraminic acid.
Hood and co-workers demonstrated that sialic acid incorpo-
ration into the LOS structure had the capability of protecting
the organism against complement mediated antibody-dependent
bactericidal activity (Hood et al., 1999). These investigators
demonstrated that a CMP-NANA synthetase mutant (siaB)
resulted in a sialylation deficient mutant, which was altered the
serum resistance of the wildtype strain.
Greiner and co-workers (Greiner et al., 2004) and Swords
and co-workers (Swords et al., 2004) demonstrated that Neu5Ac
promoted biofilm formation. Confocal and electron microscopy
demonstrated that the biofilm produced by the siaB mutant had
a significantly reduced high and a smaller mass than that formed
by the wildtype organism. After 24 h, the majority of the organ-
isms in the biofilm formed by themutant were not viable (Greiner
et al., 2004). Of note, one feature on electron microscopy was the
absence of patent water channels in the biofilm formed by the siaB
mutant. Based on this it is interesting to postulate that the sialic
acid on the LOS might be a factor in maintaining the patency of
the water channels allowing flow of nutrients and water into the
interstices of the biofilm.
Recent studies have demonstrated that the non-human sialic
acid N-glycolneuraminic (Neu5Gc) can be metabolically incor-
porated into human tissue from certain mammalian-derived
foods. Recent evidence indicates that this process can contribute
to chronic inflammation in some individuals (Surolia et al., 2010).
Studies have demonstrated that while Neu5Gc cannot be synthe-
size by bacterial species it can be taken up by NTHi and incor-
porated into its LOS surface structures. Appearance of antibodies
in infants to Neu5Gc structures correlates with nasopharyngeal
colonization with NTHi and it has been postulated that this may
be the source of these antibodies (Taylor et al., 2010). Thus,
xeno-autoantibody formation in humans may be a bystander
reaction of sialic acid incorporation during NTHi colonization
and infection.
CONCLUSIONS
NTHi is an exclusive human pathogen, which has evolved a
number of uniquemechanisms to survive within the human envi-
ronment. An important part of this is the ability of the organism
to take up and incorporate sialic acid into its surface struc-
tures. This protects the organism against host adaptive and innate
immune factor as well as serving as a mechanism for sustaining
itself within biofilms. Recent evidence suggests that this also may
be the source of the evolution of human antibodies to non-human
sialic acid structures which can lead to inflammation in the host.
Frontiers in Cellular and Infection Microbiology www.frontiersin.org March 2012 | Volume 2 | Article 19 | 5
Apicella H. influenzae sialylation
REFERENCES
Aspinall, G. O., McDonald, A. G.,
Raju, T. S., Pang, H., Kurjanczyk,
L. A., Penner, J. L., and Moran, A.
P. (1993). Chemical structure of
the core region of Campylobacter
jejuni serotype O:2 lipopolysac-
charide. Eur. J. Biochem. 213,
1029–1037.
Bozue, J. A., Tullius, M. V., Wang,
J., Gibson, B. W., and Munson, R.
S. Jr. (1999). Haemophilus ducreyi
produces a novel sialyltransferase.
Identification of the sialyltrans-
ferase gene and construction of
mutants deficient in the production
of the sialic acid-containing glyco-
form of the lipooligosaccharide. J.
Biol. Chem. 274, 4106–4114.
Brinkman-Van der Linden, E. C.,
Sjoberg, E. R., Juneja, L. R., Crocker,
P. R., Varki, N., and Varki, A. (2000).
Loss of N-glycolylneuraminic acid
in human evolution. Implications
for sialic acid recognition by
siglecs. J. Biol. Chem. 275,
8633–8640.
Colli, W. (1993). Trans-sialidase: a
unique enzyme activity discovered
in the protozoan Trypanosoma cruzi.
FASEB J. 7, 1257–1264.
Cross, G. A., and Takle, G. B. (1993).
The surface trans-sialidase family
of Trypanosoma cruzi. Annu. Rev.
Microbiol. 47, 385–411.
Edwards, U., Muller, A.,
Hammerschmidt, S., Gerardy-
Schahn, R., and Frosch, M. (1994).
Molecular analysis of the biosyn-
thesis pathway of the alpha-2,8
polysialic acid capsule by Neisseria
meningitidis serogroup B. Mol.
Microbiol. 14, 141–149.
Fleischmann, R. D., Adams, M. D.,
White, O., Clayton, R. A., Kirkness,
E. F., Kerlavage, A. R., Bult, C.
J., Tomb, J. F., Dougherty, B. A.,
Merrick, J. M., McKenney, K.,
Sutton, G., FitzHugh, W., Fields,
C., Gocayne, J. D., Scott, J., Shirley,
R., Liu, L.-I., Glodek, A., Kelley, J.
M., Weidner, J. F., Phillips, C. A.,
Spriggs, T., Hedblom, E., Cotton,
M. D., Utterbach, T. R., Hanna,
M. C., Nguyen, D. T., Saudek, D.
M., Brandon, R. C., Fine, L. D.,
Fritchman, J. L., Fuhrmann, J.
L., Geoghagen, N. S. M., Gnehm,
C. L., McDonald, L. A., Small,
K. V., Fraser, C. M., Smith, H.
O., and Venter, J. C. (1995).
Whole-genome random sequencing
and assembly of Haemophilus
influenzae Rd. Science 269,
496–512.
Fox, K. L., Cox, A. D., Gilbert,
M., Wakarchuk, W. W., Li, J.,
Makepeace, K., Richards, J. C.,
Moxon, E. R., and Hood, D.
W. (2006). Identification of a
bifunctional lipopolysaccharide
sialyltransferase in Haemophilus
influenzae: incorporation of
disialic acid. J. Biol. Chem. 281,
40024–40032.
Ganguli, S., Zapata, G., Wallis, T.,
Reid, C., Boulnois, G., Vann,
W. F., and Roberts, I. S. (1994).
Molecular cloning and analysis of
genes for sialic acid synthesis in
Neisseria meningitidis group B and
purification of the meningococcal
CMP-NeuNAc synthetase enzyme.
J. Bacteriol. 176, 4583–4589.
Gilbert, M., Brisson, J. R., Karwaski, M.
F., Michniewicz, J., Cunningham,
A. M., Wu, Y., Young, N. M.,
and Wakarchuk, W. W. (2000).
Biosynthesis of ganglioside mimics
in Campylobacter jejuni OH4384.
Identification of the glycosyltrans-
ferase genes, enzymatic synthesis
of model compounds, and charac-
terization of nanomole amounts
by 600-mhz (1)h and (13)c NMR
analysis. J. Biol. Chem. 275,
3896–3906.
Gilbert, M., Watson, D., Cunningham,
A.M., Jennings, M., Young, N.,
andWakarchuk, W. (1996). Cloning
of the Lipooligosaccharide alpha-2,
3-sialyltransferase from the bacte-
rial pathogens Neisseria meningitidis
and Neisseria gonorrhoeae. J. Biol.
Chem. 273, 28271–28276.
Greiner, L. L., Watanabe, H., Phillips,
N. J., Shao, J., Morgan, A., Zaleski,
A., Gibson, B. W., and Apicella,
M. A. (2004). Nontypeable
Haemophilus influenzae strain
2019 produces a biofilm containing
N-acetylneuraminic acid that may
mimic sialylated O-linked glycans.
Infect. Immun. 72, 4249–4260.
Guerry, P., Ewing, C. P., Hickey,
T. E., Prendergast, M. M., and
Moran, A. P. (2000). Sialylation of
lipooligosaccharide cores affects
immunogenicity and serum resis-
tance of Campylobacter jejuni.
Infect. Immun. 68, 6656–6662.
Haft, R. F., Wessels, M. R., Mebane,
M. F., Conaty, N., and Rubens,
C. E. (1996). Characterization of
cpsF and its product CMP-N-
acetylneuraminic acid synthetase,
a group B streptococcal enzyme
that can function in K1 capsular
polysaccharide biosynthesis in
Escherichia coli. Mol. Microbiol. 19,
555–563.
Hood, D. W., Cox, A. D., Gilbert,
M., Makepeace, K., Walsh, S.,
Deadman, M. E., Cody, A., Martin,
A., Mansson, M., Schweda, E.
K., Brisson, J. R., Richards, J. C.,
Moxon, E. R., and Wakarchuk,
W. W. (2001). Identification of
a lipopolysaccharide alpha-2,3-
sialyltransferase from Haemophilus
influenzae. Mol. Microbiol. 39,
341–350.
Hood, D.W.,Makepeace, K., Deadman,
M. E., Rest, R. F., Thibault, P.,
Martin, A., Richards, J. C., and
Moxon, E. R. (1999). Sialic acid
in the lipopolysaccharide of
Haemophilus influenzae: strain
distribution, influence on serum
resistance and structural char-
acterization. Mol. Microbiol. 33,
679–692.
Johnston, J. W., Coussens, N. P., Allen,
S., Houtman, J. C., Turner, K. H.,
Zaleski, A., Ramaswamy, S., Gibson,
B. W., and Apicella, M. A. (2008).
Characterization of the N-acetyl-
5-neuraminic acid-binding site of
the extracytoplasmic solute receptor
(SiaP) of nontypeable Haemophilus
influenzae strain 2019. J. Biol. Chem.
283, 855–865.
Jones, P. A., Samuels, N. M., Phillips,
N. J., Munson, R. S. Jr., Bozue,
J. A., Arseneau, J. A., Nichols, W.
A., Zaleski, A., Gibson, B. W., and
Apicella, M. A. (2002).Haemophilus
influenzae type b strain A2 has
multiple sialyltransferases involved
in lipooligosaccharide sialylation. J.
Biol. Chem. 277, 14598–14611.
Kean, E. L. (1991). Sialic acid activa-
tion. Glycobiology 1, 441–447.
Mandrell, R. E., McLaughlin, R., Aba
Kwaik, Y., Lesse, A., Yamasaki,
R., Gibson, B., Spinola, S. M.,
and Apicella, M. A. (1992).
Lipooligosaccharides (LOS) of
some Haemophilus species mimic
human glycosphingolipids, and
some LOS are sialylated. Infect.
Immun. 60, 1322–1328.
Martinez, J., Steenbergen, S., and Vimr,
E. (1995). Derived structure of the
putative sialic acid transporter from
Escherichia coli predicts a novel
sugar permease domain. J. Bacteriol.
177, 6005–6010.
Melaugh, W., Phillips, N. J.,
Campagnari, A. A., Karalus, R., and
Gibson, B.W. (1992). Partial charac-
terization of the major lipooligosac-
charide from a strain of Haemo-
philus ducreyi, the causative agent
of chancroid, a genital ulcer disease.
J. Biol. Chem. 267, 13434–13439.
Melaugh, W., Phillips, N. J.,
Campagnari, A. A., Tullius, M.
V., and Gibson, B. W. (1994).
Structure of the major oligosaccha-
ride from the lipooligosaccharide
of Haemophilus ducreyi strain
35000 and evidence for addi-
tional glycoforms. Biochemistry 33,
13070–13078.
Moran, A. P., Zahringer, U., Seydel, U.,
Scholz, D., Stutz, P., and Rietschel,
E. T. (1991). Structural analy-
sis of the lipid a component of
Campylobacter jejuni CCUG 10936
(serotype O:2) lipopolysaccharide.
Eur. J. Biochem. 198, 459–469.
Narayanan, S. (1994). Sialic acid as a
tumor marker. AnN. CliN. Lab. Sci.
24, 376–384.
Phillips, N. J., Miller, T. J., Engstrom,
J. J., Melaugh, W., McLaughlin,
R., Apicella, M. A., and Gibson,
B. W. (2000). Characterization
of chimeric lipopolysaccharides
from Escherichia coli strain JM109
transformed with lipooligosac-
charide synthesis genes (lsg) from
Haemophilus influenzae. J. Biol.
Chem. 275, 4747–4758.
Prendergast, M. M., Lastovica, A.
J., and Moran, A. P. (1998).
Lipopolysaccharides from
Campylobacter jejuni O:41 strains
associated with Guillain-Barre
syndrome exhibit mimicry of GM1
ganglioside. Infect. Immun. 66,
3649–3655.
Schauer, R., Kelm, S., Reuter, G.,
Roggentin, P., and Shaw L. (1995).
“Biochemistry and role of sialic
acids,” in Biology of the Sialic Acids,
ed A. Rosenberg (New York, NY:
Plenum Press), 7–67.
Schenkman, S., Eichinger, D., Pereira,
M. E., and Nussenzweig, V.
(1994). Structural and functional
properties of Trypanosoma trans-
sialidase. Annu. Rev. Microbiol. 48,
499–523.
Severi, E., Muller, A., Potts, J. R., Leech,
A., Williamson, D., Wilson, K. S.,
and Thomas, G. H. (2008). Sialic
acid mutarotation is catalyzed by
the Escherichia coli beta-propeller
protein YjhT. J. Biol. Chem. 283,
4841–4849.
Severi, E., Randle, G., Kivlin, P.,
Whitfield, K., Young, R., Moxon, R.,
Kelly, D., Hood, D., and Thomas,
G. H. (2005). Sialic acid trans-
port in Haemophilus influenzae is
essential for lipopolysaccharide sia-
lylation and serum resistance and
is dependent on a novel tripar-
tite ATP-independent periplasmic
transporter. Mol. Microbiol. 58,
1173–1185.
Sillanaukee, P., Ponnio, M., and
Jaaskelainen, I.P. (1999).Occurrence
of sialic acids in healthy humans
and different disorders. Eur. J.
CliN. Invest. 29, 413–425.
Surolia, I., Pirnie, S. P., Chellappa, V.,
Taylor, K. N., Cariappa, A., Moya,
J., Liu, H., Bell, D. W., Driscoll,
D. R., Diederichs, S., Haider, K.,
Netravali, I., Le, S., Elia, R., Dow,
E., Lee, A., Freudenberg, J., De
Jager, P. L., Chretien, Y., Varki,
A., Macdonald, M. E., Gillis, T.,
Frontiers in Cellular and Infection Microbiology www.frontiersin.org March 2012 | Volume 2 | Article 19 | 6
Apicella H. influenzae sialylation
Behrens, T. W., Bloch, D., Collier,
D., Korzenik, J., Podolsky, D. K.,
Hafler, D., Murali, M., Sands, B.,
Stone, J. H., Gregersen, P. K.,
and Pillai, S. (2010). Functionally
defective germline variants of sialic
acid acetylesterase in autoimmunity.
Nature 466, 243–247.
Swords, W. E., Moore, M. L., Godzicki,
L., Bukofzer, G., Mitten, M. J., and
VonCannon, J. (2004). Sialylation
of lipooligosaccharides promotes
biofilm formation by nontypeable
Haemophilus influenzae. Infect.
Immun. 72, 106–113.
Taylor, R. E., Gregg, C. J., Padler-
Karavani, V., Ghaderi, D., Yu,
H., Huang, S., Sorensen, R. U.,
Chen, X., Inostroza, J., Nizet,
V., and Varki, A. (2010). Novel
mechanism for the generation
of human xeno-autoantibodies
against the nonhuman sialic acid
N-glycolylneuraminic acid. J. Exp.
Med. 207, 1637–1646.
Tullius, M. V., Munson, R. S.
Jr., Wang, J., and Gibson,
B. W. (1996). Purification,
cloning, and expression of a
cytidine 5′-monophosphate N-
acetylneuraminic acid synthetase
from Haemophilus ducreyi. J. Biol.
Chem. 271, 15373–15380.
Varki, A. (2001). N-glycolylneuraminic
acid deficiency in humans.
Biochimie 83, 615–622.
Vimr, E., and Lichtensteiger, C. (2002).
To sialylate, or not to sialylate: that
is the question. TrendsMicrobiol. 10,
254–257.
Vimr, E. R., Bergstrom, R.,
Steenbergen, S. M., Boulnois, G.,
and Roberts, I. (1992). Homology
among Escherichia coli K1 and K92
polysialytransferases. J. Bacteriol.
174, 5127–5131.
Wakarchuk,W.W., Gilbert, M., Martin,
A., Wu, Y., Brisson, J. R., Thibault,
P., and Richards, J. C. (1998).
Structure of an alpha-2,6-sialylated
lipooligosaccharide from Neisseria
meningitidis immunotype L1. Eur. J.
Biochem. 254, 626–633.
Yamamoto, T., Nakashizuka, M.,
Kodama, H., Kajihara, Y., and
Terada, I. (1996). Purification
and characterization of a
marine bacterial beta-galactoside
alpha 2,6-sialyltransferase from
Photobacterium damsela JT0160.
J. Biochem. 120, 104–110.
Yamamoto, T., Nakashizuka, M.,
and Terada, I. (1998). Cloning
and expression of a marine
bacterial beta-galactoside alpha2,6-
sialyltransferase gene from
Photobacterium damsela JT0160.
J. Biochem. 123, 94–100.
Zapata, G., Vann, W. F., Aaronson,
W., Lewis, M. S., and Moos,
M. (1989). Sequence of the
cloned Escherichia coli K1
CMP-N-acetylneuraminic acid
synthetase gene. J. Biol. Chem. 264,
14769–14774.
Conflict of Interest Statement: The
author declares that the research
was conducted in the absence of any
commercial or financial relationships
that could be construed as a potential
conflict of interest.
Received: 20 December 2011; paper
pending published: 13 January 2012;
accepted: 07 February 2012; published
online: 13 March 2012.
Citation: Apicella MA (2012)
Nontypeable Haemophilus influen-
zae: the role of N-acetyl-5-neuraminic
acid in biology. Front. Cell. Inf. Microbio.
2:19. doi: 10.3389/fcimb.2012.00019
Copyright © 2012 Apicella. This is
an open-access article distributed under
the terms of the Creative Commons
Attribution Non Commercial License,
which permits non-commercial use, dis-
tribution, and reproduction in other
forums, provided the original authors
and source are credited.
Frontiers in Cellular and Infection Microbiology www.frontiersin.org March 2012 | Volume 2 | Article 19 | 7
